Asian markets ended higher on Tuesday on growing optimism over a corona vaccine after Moderna Inc said it had applied for US emergency authorization for its Covid-19 vaccine. Full results from a late-stage study showed that the Moderna Covid vaccine was 94.1 percent effective with no serious safety concerns. Chinese shares closed higher after data showed Caixin's China general manufacturing purchasing managers' index (PMI) rose to 54.9 in November, the highest level in a decade and compared with 53.6 in October. South Korean shares climbed as upbeat trade and manufacturing data boosted hopes of a faster than expected economic recovery from the corona virus pandemic crisis, while the country's real Gross Domestic Product (GDP) grew 2.1 percent in the July-September period from the previous quarter also offered some support. Japanese shares ended higher despite mixed economic data. The manufacturing sector in Japan continued to contract in November, the latest survey from Jibun bank revealed with a manufacturing PMI score of 49.0 up from 48.7 in October. Separate data showed that the unemployment rate in Japan increased to a seasonally adjusted 3.1 percent in October, in line with expectations and up from 3.0 percent in September.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3,451.94 | 60.18 | 1.77 |
Hang Seng | 26,567.68 | 226.19 | 0.86 |
Jakarta Composite | 5,724.74 | 112.32 | 2.00 |
KLSE Composite | 1,602.26 | 39.55 | 2.53 |
Nikkei 225 | 26,787.54 | 353.92 | 1.34 |
Straits Times | 2,814.12 | 8.17 | 0.29 |
KOSPI Composite | 2,634.25 | 42.91 | 1.66 |
Taiwan Weighted | 13,885.67 | 162.78 | 1.19 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: